Clinical Research Directory

Inclusion Criteria: Criteria related to the population: \- Subject aged between 18 and 75 years included. Criteria related to the disease: * Subject with facial vitiligo, regardless of its duration. * having a sufficient repigmentation rate of the vitiligo after repigmenting treatment Criteria related to treatments and/or products: \- Subject responder to a repigmenting treatment Non-inclusion Criteria: Criteria related to the diseases / skin condition: * Subject with active vitiligo. * Subject with spontaneous repigmentation without treatment. * Subject having other dermatological condition, an acute, chronic, or progressive disease or history of disease liable to interfere with the study assessments or considered by the Investigator hazardous for the subject or incompatible with the study requirements. Criteria related to treatments and/or products: * Systemic immunomodulatory treatment taken for another pathology, before inclusion, on-going or planned to be established during the study. * Any topical immunomodulatory treatment applied on the face for another pathology, on-going or planned to be established during the study. * Any other topical or systemic treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy according to the investigator's assessment. * Any dietary supplement for vitiligo within 4 weeks before the inclusion visit or planned to be established during the study.